QTLs in Region (Rnor_6.0)
1578646 | Bmd18 | Bone mineral density QTL 18 | 5.2 | | femur mineral mass (VT:0010011) | trabecular volumetric bone mineral density (CMO:0001729) | 15 | 26381041 | 106550657 | Rat |
1578647 | Bmd17 | Bone mineral density QTL 17 | 4 | | femur mineral mass (VT:0010011) | total volumetric bone mineral density (CMO:0001728) | 15 | 26381041 | 106550657 | Rat |
1578660 | Bss19 | Bone structure and strength QTL 19 | 4.3 | | femur morphology trait (VT:0000559) | bone trabecular cross-sectional area (CMO:0002311) | 15 | 26381041 | 106550657 | Rat |
1300144 | Rf23 | Renal function QTL 23 | 3.61 | | renal blood flow trait (VT:2000006) | absolute change in renal vascular resistance (CMO:0001900) | 15 | 43097470 | 106550657 | Rat |
1576315 | Schws6 | Schwannoma susceptibility QTL 6 | | 0.0069 | nervous system integrity trait (VT:0010566) | post-insult time of death (CMO:0002005) | 15 | 61447766 | 106447766 | Rat |
631516 | Gluco31 | Glucose level QTL 31 | 7 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 15 | 62596410 | 103164962 | Rat |
631655 | Bp126 | Blood pressure QTL 126 | 4 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 15 | 65520564 | 110520564 | Rat |
731177 | Uae26 | Urinary albumin excretion QTL 26 | 2.4 | 0.025 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 15 | 75527634 | 111246239 | Rat |
2300326 | Plaw1 | Placental weight QTL 1 | 15 | 0.005 | placenta mass (VT:0004257) | placenta wet weight (CMO:0002088) | 15 | 75761024 | 109400896 | Rat |
1331724 | Bp223 | Blood pressure QTL 223 | 3.53715 | | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 15 | 81255292 | 103165069 | Rat |
1641889 | Colcr6 | Colorectal carcinoma resistance QTL 6 | 2.9 | 0.0126 | intestine integrity trait (VT:0010554) | benign colorectal tumor surface area measurement (CMO:0001799) | 15 | 81255292 | 109133904 | Rat |
70182 | BpQTLcluster12 | Blood pressure QTL cluster 12 | 3.53 | | arterial blood pressure trait (VT:2000000) | absolute change in mean arterial blood pressure (CMO:0000533) | 15 | 81255430 | 103164962 | Rat |
70155 | Gcs1 | Gastric cancer susceptibility QTL1 | 3.8 | | stomach morphology trait (VT:0000470) | stomach tumor susceptibility score (CMO:0002043) | 15 | 83947714 | 111246239 | Rat |
1549844 | Bss7 | Bone structure and strength QTL 7 | 6.4 | | femur strength trait (VT:0010010) | femur midshaft polar moment of inertia (CMO:0001669) | 15 | 84050550 | 111246239 | Rat |
2317055 | Aia10 | Adjuvant induced arthritis QTL 10 | 3.41 | | joint integrity trait (VT:0010548) | left rear ankle joint diameter (CMO:0002149) | 15 | 84050550 | 111246239 | Rat |
1300118 | Bp190 | Blood pressure QTL 190 | 2.94 | | arterial blood pressure trait (VT:2000000) | blood pressure measurement (CMO:0000003) | 15 | 89640684 | 106550657 | Rat |
1300120 | Kidm7 | Kidney mass QTL 7 | 3.55 | | kidney mass (VT:0002707) | left kidney wet weight to body weight ratio (CMO:0001954) | 15 | 89640684 | 106550657 | Rat |
1581519 | Cm59 | Cardiac mass QTL 59 | 2.8 | 0.05 | heart left ventricle mass (VT:0007031) | heart left ventricle weight to body weight ratio (CMO:0000530) | 15 | 96777066 | 104003672 | Rat |
2300159 | Bmd61 | Bone mineral density QTL 61 | 5.3 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 27597761 | Rat |
2300183 | Bmd60 | Bone mineral density QTL 60 | 5.7 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 27597761 | Rat |
619619 | Rf4 | Renal disease susceptibility QTL 4 | 4.1 | 0.002 | total urine protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 14 | 1 | 34403399 | Rat |
9589814 | Gluco67 | Glucose level QTL 67 | 4.54 | 0.001 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 1 | 41333960 | Rat |
7411573 | Bw139 | Body weight QTL 139 | 4.7 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 14 | 1 | 41333960 | Rat |
634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 42766285 | Rat |
71115 | Niddm15 | Non-insulin dependent diabetes mellitus QTL 15 | 4.8 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 2227825 | 12680613 | Rat |
70204 | Niddm20 | Non-insulin dependent diabetes mellitus QTL 20 | 5.1 | 0.000008 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 14 | 2227825 | 19230541 | Rat |
724541 | Niddm53 | Non-insulin dependent diabetes mellitus QTL 53 | | 0.001 | blood glucose amount (VT:0000188) | blood glucose level area under curve (AUC) (CMO:0000350) | 14 | 4833233 | 10729268 | Rat |
2293089 | Iddm31 | Insulin dependent diabetes mellitus QTL 31 | 4.7 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 4833233 | 19909932 | Rat |
2293089 | Iddm31 | Insulin dependent diabetes mellitus QTL 31 | 4.7 | | blood glucose amount (VT:0000188) | age at onset/diagnosis of type 1 diabetes mellitus (CMO:0001140) | 14 | 4833233 | 19909932 | Rat |
1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 4833233 | 23004027 | Rat |
70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 4833233 | 26466248 | Rat |
1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 4833233 | 33040042 | Rat |